Could COVID-19 hold a cancer cure? Spikeprotein reduces lung tumors in lab study
Intranasal administration of recombinant SARS-CoV-2 spike S1 causes regression of lung tumor in NNK-insulted female A/J mice. The experimental design is illustrated for NNK-induced lung cancer in A/J mice . Briefly, female A/J mice received two intraperitoneal injections of NNK one week apart. Tumor development was analyzed after 26 weeks of NNK intoxication.
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Co-infecting pathogens and the microbiome from SARS-CoV-2 positive and negative samplesCo-infecting pathogens and the microbiome from SARS-CoV-2 positive and negative samples PLOSONE jgi pathogen microbiome SARSCoV2 COVID19 coronavirus covid
Consulte Mais informação »
Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2 biorxivpreprint WUSTLmed SARSCoV2 COVID19 coronavirus covid infection
Consulte Mais informação »
Impact of COVID-19 booster vaccination and breakthrough infectionResearchers assessed the protection elicited after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccination or a breakthrough infection against SARS-CoV-2 Omicron variant infection.
Consulte Mais informação »
Study provides understanding of SARS-CoV-2 pulmonary infection long-term effects at the microanatomical, cellular, and molecular levelStudy provides understanding of SARS-CoV-2 pulmonary infection long-term effects at the microanatomical, cellular, and molecular level medrxivpreprint WeillCornell SARSCoV2 COVID19 coronavirus covid infection pulmonary
Consulte Mais informação »
Wearing glasses does not reduce risk of COVID-19Wearing glasses does not reduce risk of COVID-19 Coronavirus Disease COVID Glasses EyeGlasses Ophthalmology JAMANetworkOpen Folkehelseinst OsloMet UniBasel Stanford berlinnovation
Consulte Mais informação »
Is remdesivir treatment associated with reduced risk of inpatient mortality among US patients hospitalized with COVID-19?Researchers assessed the effect of remdesivir on inpatient COVID-19-associated mortality among individuals hospitalized with SARS-CoV-2 infections in an enormous dataset of US residents beyond clinical trial settings.
Consulte Mais informação »